Common Contracts
5 similar null contracts by Cumberland Pharmaceuticals Inc
Effective January 1, 2024 Todd Anthony Franklin, TN 37064Cumberland Pharmaceuticals Inc • March 13th, 2024 • Pharmaceutical preparations
Effective January 1, 2024, this agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”). In consideration of your appointment as Vice President Organizational Development of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
Effective January 1, 2024 Nashville, TN 37203Cumberland Pharmaceuticals Inc • March 13th, 2024 • Pharmaceutical preparations
Effective January 1, 2024, this agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”). In consideration of your appointment as Chief Executive Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
Effective January 1, 2024 Chris Bitterman Nashville, TN 37208Cumberland Pharmaceuticals Inc • March 13th, 2024 • Pharmaceutical preparations
Effective January 1, 2024, this agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”). In consideration of your appointment as Vice President Sales & Marketing of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
Effective January 1, 2024 John Hamm Brentwood, TN 37207Cumberland Pharmaceuticals Inc • March 13th, 2024 • Pharmaceutical preparations
Effective January 1, 2024, this agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”). In consideration of your appointment as Vice President, Chief Financial Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
Effective January 1, 2024 James “Jim” Herman Nashville, TN 37211Cumberland Pharmaceuticals Inc • March 13th, 2024 • Pharmaceutical preparations
Effective January 1, 2024, this agreement (the “Agreement”) will evidence the terms and conditions under which you will be employed by Cumberland Pharmaceuticals Inc. (the “Company”). In consideration of your appointment as Executive Vice President National Accounts, Chief Compliance Officer of the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
